Trimetazidine as an adjunct to standard hydration reduces the incidence of contrast-induced acute kidney injury in patients with renal insufficiency undergoing coronary angiography or percutaneous cardiac intervention: a systematic review and meta-analysis.

Abstract Background Contrast-induced acute kidney injury (CI-AKI) is a known complication after coronary angiography (CAG) or percutaneous coronary intervention (PCI). Clinical evidence suggests that trimetazidine (TMZ), an anti-ischemic drug, may prevent CI-AKI. We aimed to evaluate the role of tri...

Cijeli opis

Bibliografski detalji

Glavni autori:	Andrew Lukwaro, Yi Lu, Junzhe Chen, Ying Tang
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2024-12-01
Serija:	BMC Nephrology
Teme:	Randomized controlled trials contrast-induced acute kidney injury Contrast-induced nephropathy Trimetazidine Renal insufficiency Coronary angiography
Online pristup:	https://doi.org/10.1186/s12882-024-03872-9
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!